Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
430.00    6.00 (1.42%)
Bid:
424.50
Ask:
430.00
Spread: 5.50 (1.296%)
Market Cap: £211.48m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

7 Nov 2023 07:00

RNS Number : 3591S
Zotefoams PLC
07 November 2023
 

Zotefoams plc

("Zotefoams" or "Group")

 

Trading Update

"Delivering on strategy - profit in line with market expectations"

 

7 November 2023 - Zotefoams, a world leader in cellular materials technology, today provides a trading update for the nine months ended 30 September 2023 ("year to date") and in respect of its financial year ending 31 December 2023.

Notwithstanding the challenging economic backdrop, the Group has continued to deliver a resilient performance, with year-to-date sales at a similar level to the comparative period of 2022, benefiting from a modest currency tailwind.

As anticipated, third quarter sales were lower year on year, reflecting subdued demand in most Polyolefin Foams markets, together with lower economic activity in China and an inventory adjustment in the supply chain to Nike. Against this backdrop, the Group continues to take effective pricing, cost and capacity management actions, which have enabled the business to remain agile and respond quickly to the volatility in demand dynamics.

The Group has also continued to invest in the development of ReZorce® recyclable barrier packaging technology and, following the signing of a joint development agreement, has made further progress against the milestones set, in advance of commercial trials scheduled for early 2024.

Full year expectation

The Group has good visibility of confirmed orders for the remainder of the year and expects to deliver revenue for 2023 at a similar level to 2022, albeit with an improved product mix.

Across our two foams business units, profitability for 2023 will see the positive benefit from an increasing proportion of sales from the HPP division, as well as the effect of strong pricing and operational efficiencies within Polyolefin Foams. Together with more favourable raw material and energy prices, this is expected to drive improved overall profitability, with margins significantly higher than the previous year.

In our MEL business unit, costs will increase as we further invest in ReZorce and address some legacy issues in the licensing and equipment business. The MEL business unit is now predominantly focused on the development of the ReZorce recyclable barrier packaging solution for beverage cartons. 

The Board is confident in the Group's ability to carry positive momentum through the remainder of the year. Based on its current sales forecasts and foreign exchange rates, and subject to there being no material disruption to the business, it expects adjusted profit before tax to be in line with current market expectations*.

 

Commenting on the update David Stirling, Group CEO of Zotefoams, said: 

"The Group is delivering on its strategy to drive efficiencies and generate an enhanced sales mix in its foams business units, and we anticipate a strong final quarter to the year and good underlying growth in profitability in this part of the Group, despite lower economic activity and destocking in many markets recently.

"We are also delivering on our commitment to develop recyclable beverage cartons. Investment in the high-risk, high-reward ReZorce technology is tracking in line with management expectations ahead of market trials and represents a significant proportion of Group costs, which are evaluated continuously in the context of the wider Group performance and the very significant opportunity represented by its target markets.

"These are two very different businesses with different organisational and operational requirements, which we are delivering to a high standard."

 

* Current Zotefoams-compiled consensus expectations for adjusted profit before income tax and separately disclosed items, for the year ending 31 December 2022, is £12.5m.

 

 - Ends -

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

 

 

IFC Advisory

 

+44 (0) 203 934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

www.zotefoams.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPGWUGUPWGUW
Date   Source Headline
10th Aug 200912:45 pmRNSHolding(s) in Company
4th Aug 20097:00 amRNSHalf Yearly Report
20th Jul 20091:42 pmRNSHolding(s) in Company
3rd Jul 20097:00 amRNSTrading Statement
17th Jun 20095:33 pmRNSHolding(s) in Company
5th Jun 200912:23 pmRNSDirector/PDMR Shareholding
19th May 200910:30 amRNSAnnual Information Update
12th May 200910:30 amRNSVoting Rights and Capital
7th May 20097:00 amRNSAGM Statement
7th Apr 200910:51 amRNSNotice of AGM
26th Mar 20097:00 amRNSAdditional Listing
18th Mar 20091:50 pmRNSDirector/PDMR Shareholding
16th Mar 20095:19 pmRNSDirector/PDMR Shareholding
10th Mar 20097:00 amRNSFinal Results
22nd Jan 200911:36 amRNSHolding(s) in Company
5th Jan 20091:19 pmRNSVoting Rights and Capital
19th Dec 20087:00 amRNSTrading Statement
12th Dec 200811:04 amRNSDirector/PDMR Shareholding
11th Dec 20082:20 pmRNSHolding(s) in Company
3rd Nov 20087:00 amRNSInterim Management Statement
30th Oct 20082:25 pmRNSAdditional Listing
14th Aug 20087:00 amRNSDirector/PDMR Shareholding
5th Aug 20087:00 amRNSInterim Results
9th Jul 20089:11 amRNSAcquires Stake
1st Jul 20087:00 amRNSTrading Update
5th Jun 20089:37 amRNSVoting rights and capital
23rd May 20085:38 pmRNSAnnual Information Update
8th May 20087:01 amRNSAGM Statement
14th Apr 20087:00 amRNSBlocklisting Interim Review
8th Apr 20086:07 pmRNSAdditional Listing
8th Apr 20088:18 amRNSNotice of AGM
25th Mar 20082:46 pmRNSDirector/PDMR Shareholding
4th Mar 20087:01 amRNSFinal Results
3rd Mar 20087:00 amRNSCustomer Achievement
1st Feb 20081:46 pmRNSTotal Voting Rights
21st Dec 20072:48 pmRNSDirectors' Shareholdings
26th Nov 200710:04 amRNSAdditional Listing
12th Nov 20077:01 amRNSDirector/PDMR Shareholding
7th Nov 20078:45 amRNSDirectors' Shareholdings
30th Oct 20072:55 pmRNSHolding in Company
19th Oct 20077:01 amRNSProduct Achievement
17th Oct 20079:32 amRNSBlocklisting Interim Review
5th Sep 200712:29 pmRNSHolding(s) in Company
28th Aug 20077:02 amRNSMarketing Alliance
7th Aug 20077:00 amRNSInterim Results
30th Jul 20074:45 pmRNSVoting rights & capital
12th Jul 20074:02 pmRNSDirectorate Change
29th Jun 200711:04 amRNSTrading Update
28th Jun 20072:23 pmRNSHolding(s) in Company
21st May 200712:03 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.